Dietary formulation for Diabetes

Clinical efficacy of a unique dietary formulation in type 2 diabetes. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/066629

Enrollment

100

Registered

2024-05-01

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Participants with Type 2 Diabetes mellitus on Oral Hypoglycemic Agents or insulin for at least 4 weeks that is not anticipated to change during the study. Participants with Type 2 diabetes without medication HbA1c = 6.5 Participants willing for inclusion in clinical trial.

Exclusion criteria

Exclusion criteria: Any neurological condition requiring urgent medical intervention. Any other serious systemic disease in last 3 months. Subjects having malignancies, serious infections as well as those requiring long term steroids and hormonal treatment. Pregnant and lactating women. Subjects having H/O renal transplant.

Design outcomes

Primary

Measure	Time frame
Reduction in Fasting & postprandial blood sugar level Reduction in HbA1c Timepoint: Baseline 30th and 60th	—

Secondary

Measure	Time frame
Weight loss Reduction in abdominal, chest & hip circumference Timepoint: Baseline 30th 60th and 90th day	—

Countries

India

Contacts

Public ContactProf Dr Swati Mohite

Bharati Vidyapeeth (Deemed to be University)

dr.ssmohite@gmail.com9822004562

Outcome results